VANGUARD GROUP INC 13D and 13G filings for Bio-Techne Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:00 pm Purchase | 2023-12-29 | 13G | Bio-Techne Corporation TECH | VANGUARD GROUP INC | 18,228,210 11.530% | 28,778 (+0.16%) | Filing |
| 2023-02-09 11:12 am Purchase | 2022-12-30 | 13G | Bio-Techne Corporation TECH | VANGUARD GROUP INC | 18,199,432 11.590% | 492,880 (+2.78%) | Filing |
| 2022-02-09 3:33 pm Purchase | 2021-12-31 | 13G | Bio-Techne Corporation TECH | VANGUARD GROUP INC | 17,706,552 11.270% | 444,380 (+2.57%) | Filing |
| 2021-09-10 09:42 am Purchase | 2021-08-31 | 13G | Bio-Techne Corporation TECH | VANGUARD GROUP INC | 17,262,172 11.040% | 2,896,764 (+20.16%) | Filing |
| 2021-02-10 10:39 am Purchase | 2020-12-31 | 13G | Bio-Techne Corporation TECH | VANGUARD GROUP INC | 14,365,408 9.300% | 90,200 (+0.63%) | Filing |
| 2020-02-12 07:57 am Purchase | 2019-12-31 | 13G | Bio-Techne Corporation TECH | VANGUARD GROUP INC | 14,275,208 9.360% | 500,212 (+3.63%) | Filing |